[Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].

Abstract

OBJECTIVE:

To detect serum v-raf murine sarcoma viral oncogene homologue B1 (BRAF) protein levels and to investigate their clinical significance in rheumatoid arthritis (RA) patients.

METHODS:

Serum samples were obtained from 78 RA patients, 32 osteoarthritis (OA) patients, 16 systemic lupus erythematosus (SLE) patients, 16 gout patients, 16 ankylosing spondylitis (AS) patients, 16 Sjogren syndrome (SS) patients and 30 healthy controls. BRAF protein in the sera was examined by enzyme-linked immunosorbent assay (ELISA). The associations between BRAF levels and the clinical features including age, sex, disease duration, swelling joints, tenderness joints, duration of moning stiffness, joint deformity, visual assessment scale (VAS) and extra articular manifestations and laboratory parameters including erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), disease activity score in 28 joints (DAS28), anti-cyclic citrullinated peptide (CCP) antibody, antikeratin antibody, antnuclear antibody (ANA), immunoglobulin and cytokines, such as TNF-α, IL-1β, IL-6 and IL-17A in RA patients were evaluated. Data analyses were performed by using SPSS 19.0 program.

RESULTS:

The serum BRAF protein levels in the RA patients were significantly higher than those of other rheumatic diseases groups including OA, SLE, AS, SS, gout patients and healthy controls, the P value was 0.002, <0.001, <0.001, <0.001, 0.001 and <0.001 respectively. The level of serum BRAF protein in the RA patients showed a positive correlation with the rheumatoid factor (P=0.009) and IgA levels (P=0.006), but no correlation with clinical features, such as age and duration or other laboratory parameters, including CRP, ESR, anti-CCP antibody, IgM, IgG, TNF-α, IL-1β, IL-6 and IL-17A. The RA patients were further divided into normal levels of BRAF protein group and elevated levels of BRAF protein group. Compared with the clinical features and laboratory indexes of normal and elevated levels of BRAF protein groups in the RA patients, there was no significant difference between the two groups in age, duration, DAS28, CRP, ESR, RF, anti-CCP, IgA, IgG, IgM, TNF-α or IL-6.

CONCLUSION:

The elevated level of BRAF protein in the RA patients showed that BRAF might play a role in the pathogenesis of RA. Further researches on BRAF gene expression may help to clarify the role of BRAF in RA.

• Authors: Y J Jin, L Sun, L Yang, R Xing, X Y Liu
• Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences (Beijing Da Xue Xue Bao Yi Xue Ban) Vol. 48 Issue 6 Pg. 947-950 (12 18 2016) ISSN: 1671-167X [Print] China
• PMID: 27987495 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Autoantibodies
• Cytokines
• IL17A protein, human
• Immunoglobulins
• Interleukin-17
• Interleukin-6
• Peptides, Cyclic
• Tumor Necrosis Factor-alpha
• cyclic citrullinated peptide
• C-Reactive Protein
• Rheumatoid Factor
• BRAF protein, human
• Proto-Oncogene Proteins B-raf

Topics

• Arthritis, Rheumatoid (classification, genetics, physiopathology)
• Autoantibodies
• Blood Sedimentation
• C-Reactive Protein
• Cytokines
• Enzyme-Linked Immunosorbent Assay
• Female
• Humans
• Immunoglobulins
• Interleukin-17
• Interleukin-6
• Male
• Osteoarthritis
• Peptides, Cyclic
• Proto-Oncogene Proteins B-raf (immunology)
• Rheumatoid Factor
• Sjogren's Syndrome
• Spondylitis, Ankylosing
• Tumor Necrosis Factor-alpha